Thomas Ciulla's Net Worth
$334 Thousand
Who is Thomas Ciulla?
Thomas Ciulla does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Clearside Biomedical, Inc., and Viridian Therapeutics, Inc.\DE.
SEC CIK
Thomas Ciulla's CIK is 0001815426
Past Insider Trading and Trends
2022 was Thomas Ciulla's most active year for acquiring shares with 6 total transactions. Thomas Ciulla's most active month to acquire stocks was the month of December. 2023 was Thomas Ciulla's most active year for disposing of shares, totalling 2 transactions. Thomas Ciulla's most active month to dispose stocks was the month of December. 2022 saw Thomas Ciulla paying a total of $11,000.00 for 370,000 shares, this is the most they've acquired in one year. In 2023 Thomas Ciulla cashed out on 15,870 shares for a total of $23,654.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Clearside Biomedical, Inc. (CLSD) Snapshot price: $0.9799
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.48% | -13.70K |
$1.47 | -$20,139.00 | 291.89K |
Scheduled
|
Jan 20
| ||
Form 4
| -0.71% | -2.17K |
$1.62 | -$3,515.40 | 305.59K |
Scheduled
|
Jan 10
| ||
Form 4
| +3.36% | 10K |
$1.10 | $11,000.00 | 307.76K |
Jun 30 - Jan 4
| |||
Form 4/A
| +18.10% | 46.25K |
—
|
—
| 301.81K |
Jan 18
| |||
Form 4
| +6.20% | 34.7K |
$2.13 | -$19,276.50 | 594.57K |
Scheduled
|
Jan 18 - Jan 19
| ||
Form 4
| -0.99% | -2.56K |
$6.40 | -$16,384.00 | 255.56K |
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +68.75% | 103.13K |
—
|
—
| 253.12K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||